114 related articles for article (PubMed ID: 9547434)
1. The analysis of small-sample multivariate data.
Saranadasa H; Altan S
J Biopharm Stat; 1998 Mar; 8(1):163-86. PubMed ID: 9547434
[TBL] [Abstract][Full Text] [Related]
2. A multivariate two-sample mean test for small sample size and missing data.
Wu Y; Genton MG; Stefanski LA
Biometrics; 2006 Sep; 62(3):877-85. PubMed ID: 16984331
[TBL] [Abstract][Full Text] [Related]
3. Tests for inter-subject and total variabilities under crossover designs.
Lee Y; Shao J; Chow SC; Wang H
J Biopharm Stat; 2002 Nov; 12(4):503-34. PubMed ID: 12477072
[TBL] [Abstract][Full Text] [Related]
4. Power of pairwise comparisons in the equal variance and unequal sample size case.
Ramsey PH; Ramsey PP
Br J Math Stat Psychol; 2008 May; 61(Pt 1):115-31. PubMed ID: 18482478
[TBL] [Abstract][Full Text] [Related]
5. Large sample tests for binary outcomes in fixed-dose combination drug studies.
Wang SJ; Hung HM
Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
[TBL] [Abstract][Full Text] [Related]
6. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models.
Candel MJ; Van Breukelen GJ
Stat Med; 2009 Aug; 28(18):2307-24. PubMed ID: 19472169
[TBL] [Abstract][Full Text] [Related]
7. A method for comparing two normal means using combined samples of correlated and uncorrelated data.
Looney SW; Jones PW
Stat Med; 2003 May; 22(9):1601-10. PubMed ID: 12704618
[TBL] [Abstract][Full Text] [Related]
8. Sample size planning with the cost constraint for testing superiority and equivalence of two independent groups.
Guo JH; Chen HJ; Luh WM
Br J Math Stat Psychol; 2011 Nov; 64(3):439-61. PubMed ID: 20704777
[TBL] [Abstract][Full Text] [Related]
9. Group sequential t-test for clinical trials with small sample sizes across stages.
Shao J; Feng H
Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
[TBL] [Abstract][Full Text] [Related]
10. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
Ogungbenro K; Aarons L
J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
[TBL] [Abstract][Full Text] [Related]
11. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
Lui KJ; Chang KC
Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
[TBL] [Abstract][Full Text] [Related]
12. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
13. Sample size determination based on rank tests in clinical trials.
Wang H; Chen B; Chow SC
J Biopharm Stat; 2003 Nov; 13(4):735-51. PubMed ID: 14584719
[TBL] [Abstract][Full Text] [Related]
14. Nonparametric comparison for panel count data with unequal observation processes.
Zhao X; Sun J
Biometrics; 2011 Sep; 67(3):770-9. PubMed ID: 21114659
[TBL] [Abstract][Full Text] [Related]
15. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
[TBL] [Abstract][Full Text] [Related]
16. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
Dallow NS; Leonov SL; Roger JH
Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
[TBL] [Abstract][Full Text] [Related]
17. Detecting data fabrication in clinical trials from cluster analysis perspective.
Wu X; Carlsson M
Pharm Stat; 2011; 10(3):257-64. PubMed ID: 20936626
[TBL] [Abstract][Full Text] [Related]
18. Sample size re-estimation in group-sequential response-adaptive clinical trials.
Morgan CC
Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
[TBL] [Abstract][Full Text] [Related]
19. Sample size calculation for the van Elteren test adjusting for ties.
Zhao YD; Rahardja D; Mei Y
J Biopharm Stat; 2008; 18(6):1112-9. PubMed ID: 18991111
[TBL] [Abstract][Full Text] [Related]
20. Performance and sample size requirements of Bayesian methods for binary outcomes in fixed-dose combination drug studies.
Holt MM; Stamey JD; Seaman JW; Young DM
J Biopharm Stat; 2009; 19(1):120-32. PubMed ID: 19127471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
